Eli Lilly and Co (LLY)
550.54
+0.41
(+0.07%)
USD |
NYSE |
Sep 22, 16:00
550.00
-0.54
(-0.10%)
After-Hours: 20:00
Eli Lilly Income from Discontinued Operations (Quarterly)
Income from Discontinued Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Income from Discontinued Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
| June 30, 2014 | -- |
| March 31, 2014 | -- |
| December 31, 2013 | -- |
| Date | Value |
|---|---|
| September 30, 2013 | -- |
| June 30, 2013 | -- |
| March 31, 2013 | -- |
| December 31, 2012 | -- |
| September 30, 2012 | -- |
| June 30, 2012 | -- |
| March 31, 2012 | -- |
| December 31, 2011 | -- |
| September 30, 2011 | -- |
| June 30, 2011 | -- |
| March 31, 2011 | -- |
| December 31, 2010 | -- |
| September 30, 2010 | -- |
| June 30, 2010 | -- |
| March 31, 2010 | -- |
| December 31, 2009 | -- |
| September 30, 2009 | -- |
| June 30, 2009 | -- |
| March 31, 2009 | -- |
| December 31, 2008 | -- |
| September 30, 2008 | -- |
| June 30, 2008 | -- |
| March 31, 2008 | -- |
| December 31, 2007 | -- |
| September 30, 2007 | -- |
Income from Discontinued Operations Definition
Income from operations that used to be a part of the business but are not any longer. This could be due to the sale of a portion of a business, shutting down a division, or something else.
Income from Discontinued Operations (Quarterly) Range, Past 5 Years
Income from Discontinued Operations (Quarterly) Benchmarks
| Amgen Inc | -- |
| Biogen Inc | -- |
| Johnson & Johnson | -- |
| Merck & Co Inc | -- |
| Pfizer Inc | Upgrade |